Johnson & Johnson, US4781601046

Johnson & Johnson stock pre-market at EUR 234.08: plus 0.03 percent

Published on 10/01/2026 at 07:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock was at EUR 234.08 pre-market at Lang & Schwarz, up 0.03 percent versus the prior close. The company’s latest listed release concerns ACUVUE OASYS MAX reusable contact lenses.

Modern hospital operating room with robotic surgical arms positioned above a draped patient, surgeons in blue sterile gowns monitoring vital-sign and anatomy screens, bright overhead surgical lighting, stainless steel instrument trays in the foreground
Johnson und US4781601046 zeigen modernen Krankenhaus OP mit Robotik Chirurgie und medizinischen Bildschirmen, Illustration mit AI erstellt.

Johnson & Johnson stock was at EUR 234.08 pre-market on October 1, 2026, at 7:38 a.m. CEST, according to Lang & Schwarz. The price was up 0.03 percent versus the Lang & Schwarz prior close of EUR 234.00 on September 30, 2026.

Pre-market trading

Lang & Schwarz showed a bid of EUR 234.05 and an ask of EUR 234.10. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Johnson & Johnson stock.

Latest company announcement

In its latest listed press-release update, Johnson & Johnson said on September 10, 2026, that it had received CE Marking for ACUVUE OASYS MAX reusable contact lenses. The company described the product as a new two-week reusable lens designed to extend the ACUVUE OASYS MAX portfolio, according to Johnson & Johnson.

Disclaimer...

en | US4781601046 | JOHNSON & JOHNSON | boerse | 70207844 | bgmi